A comparison of treatment results for recurrent malignant gliomas

Cancer Treatment Reviews

Volumn 26, Issue 6, 2000, Pages 397-409

  Nieder, C ^a   Grosu, A L ^a   Molls, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chemotherapy; High grade gliomas; Malignant gliomas; Radiotherapy; Recurrent gliomas; Surgery; Therapy

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE ANTIBIOTIC AGENT; BENZNIDAZOLE; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYTOSTATIC AGENT; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; LOMUSTINE; NITROSOUREA DERIVATIVE; PACLITAXEL; PLATINUM DERIVATIVE; PROCARBAZINE; RADIOSENSITIZING AGENT; RETINOIC ACID; TAMOXIFEN; TAXANE DERIVATIVE; TEMOZOLOMIDE; THALIDOMIDE;

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; GENE THERAPY; GLIOBLASTOMA; HUMAN; MONOTHERAPY; NEUROTOXICITY; PATIENT SELECTION; PROGNOSIS; QUALITY OF LIFE; RADIOSURGERY; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; REVIEW; SOMNOLENCE; STEREOTAXIC SURGERY;

EID: 0034515477     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1053/ctrv.2000.0191     Document Type: Review

References (62)

1. A review of current and future treatment strategies for malignant astrocytomas in adults
2. The fallacy of the localized supratentorial malignant glioma
3. Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local therapy
4. Assumptions in the radiotherapy of glioblastoma
5. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost
6. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
7. Patterns of failure following 3-D conformal dose escalation radiotherapy for high grade astrocytomas - A quantitative dosimetric study
8. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas
9. Bihemispheric malignant glioma: One size does not fit all
10. Treatment of recurrent high grade astrocytomas: Results of a systematic review of 1415 patients
11. The quality of medical evidence in Hematology-Oncology
12. Users guide to the medical literature. IX. A method for grading health care recommendations
13. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
14. A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma
15. Efficacy of "8-drugs-in-one-day" combination in treatment of recurrent GBM patients
16. Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosurea wafer implantation for recurrent glioblastoma: A retrospective case-matched cohort series
17. Indication for repeat surgery of glioblastoma: Influence of progress of disease
18. Reoperation for recurrent glioblastoma and anaplastic astrocytoma
19. Re-operation for glioblastoma
20. Multimodality management of recurrent adult malignant gliomas: Results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery
21. Survival and functional status after resection of recurrent glioblastoma multiforme
22. Reoperation in the treatment of recurrent intracranial malignant gliomas
23. Re-operations of supratentorial anaplastic astrocytomas
24. Treatment of recurrent malignant supratentorial gliomas with carboplatin
25. Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: A phase II study
26. Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: A phase II study
27. Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas
28. Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine - A phase-II study
29. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high-grade glioma
30. Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results
31. Irinotecan therapy in adults with recurrent or progressive malignant glioma
32. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials
33. Salvage chemotherapy with taxol for recurrent anaplastic astrocytomas
34. Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme
35. Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas
36. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
37. Chemotherapy in the treatment of recurrent glioblastoma multiforme: Ifosfamide versus temozolomide
38. The Charing Cross Hospital experience with temozolomide in patients with gliomas
39. Carboplatin and etoposide for recurrent malignant glioma following surgical and radiotherapy failure
40. Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma
41. Procarbazine and high-dose tamoxiten as a second-line regimen in recurrent high-grade gliomas: A phase II study
42. KRN8602 (MX2- Hydrochloride): An active new agent for the treatment of recurrent high-grade glioma
43. Salvage chemotherapy with paclitaxel for recurrent primary brain tumors
44. All-trans-retinoic acid: A phase II RTOG study in patients with recurrent malignant astrocytoma
45. Response criteria for phase II studies of supratentorial malignant glioma
46. Hyperfractionated reirradiation for malignant glioma
47. The value of radiosurgery for recurrent glioblastoma multiforme [German]
48. Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: A preliminary report
49. Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy
50. Retreatment of patients with intracranial gliomas by external beam radiotherapy and cytotoxic chemotherapy
51. Reirradiation and lomustine in patients with relapsed high-grade gliomas
52. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma
53. A phase 1 dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma
54. Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma
55. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases
56. Stereotactic radiosurgery for recurrent gliomas
57. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme
58. Permanent 125-iodine implants for recurrent malignant gliomas
59. Thermoradiotherapy of recurrent malignant brain tumors
60. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
61. A phase I/II study of herpes simplex virus type 1 thymidine kinase suicide gene therapy for recurrent glioblastoma
62. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas